1-20 of 39
Wendy Stock
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of prior inotuzumab ozogamicin treatment on brexucabtagene autoleucel outcomes in adults with B-cell ALL

Clinical Trials & Observations
Ibrahim Aldoss, Gregory W. Roloff, Rawan Faramand, Noam E. Kopmar, Chenyu Lin, Anjali S. Advani, Simone E. Dekker, Vishal K. Gupta, Timothy E. O'Connor, Nikeshan Jeyakumar, Ibrahim N. Muhsen, Yannis Valtis, Amy Zhang, Katharine Miller, Katherine Sutherland, Kaitlyn C. Dykes, Mohamed Ahmed, Evan Chen, Hector Zambrano, Danielle Bradshaw, Santiago Mercadal, Marc Schwartz, Sean Tracy, Bhagirathbhai Dholaria, Michal Kubiak, Akash Mukherjee, Navneet Majhail, Minoo Battiwalla, Luke Mountjoy, Shahbaz A. Malik, John Mathews, Paul Shaughnessy, Aaron C. Logan, Abdullah Ladha, Maryann Stefan, Caitlin Guzowski, Rasmus T. Hoeg, Talal Hilal, Jozal Moore, Matthew Connor, Kristen M. O'Dwyer, LaQuisa C. Hill, Stephanie B. Tsai, Joshua Sasine, Melhem M. Solh, Catherine J. Lee, Vamsi K. Kota, Divya Koura, Muthu Veeraputhiran, Betsy Blunk, Caspian Oliai, Jessica T. Leonard, Noelle V. Frey, Jae H. Park, Marlise R. Luskin, Veronika Bachanova, Ahmed Galal, Michael R. Bishop, Wendy Stock, Ryan D. Cassaday, Vinod Pullarkat, Bijal D. Shah, Lori S. Muffly
Journal: Blood Advances
Blood Adv (2024) 8 (23): 6139–6147.
https://doi.org/10.1182/bloodadvances.2024013747
Published: 2024
Includes: Supplemental data
Journal Articles

A multicenter phase 2 clinical trial of low-dose subcutaneous decitabine in myelofibrosis

Clinical Trials & Observations
Chenyu Lin, Anand A. Patel, Dezheng Huo, Theodore Karrison, Koen van Besien, John Godwin, Dorie Sher, Howie Weiner, Margaret Green, James L. Wade, III, Rebecca Klisovic, Maria R. Baer, Richard A. Larson, Wendy Stock, Olatoyosi Odenike
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5735–5743.
https://doi.org/10.1182/bloodadvances.2024013215
Published: 2024
Includes: Supplemental data
Journal Articles

Medicaid Coverage Continuity is Associated with Lymphoma Stage among Children and Adolescents/Young Adults

Xinyue Zhang, Sharon M Castellino, Robin Yabroff, Wendy Stock, Patricia Heyer Cornwell, Shasha Bai, Ann C Mertens, Joseph Lipscomb, Xu Ji
Journal: Blood Advances
Blood Adv bloodadvances.2024013532.
https://doi.org/10.1182/bloodadvances.2024013532
Published: 2024
Includes: Supplemental data
Journal Articles

Beat-AML 2024 ELN–refined risk stratification for older adults with newly diagnosed AML given lower-intensity therapy

Fieke W. Hoff, William G. Blum, Ying Huang, Rina Li Welkie, Ronan T. Swords, Elie Traer, Eytan M. Stein, Tara L. Lin, Kellie J. Archer, Prapti A. Patel, Robert H. Collins, Maria R. Baer, Vu H. Duong, Martha L. Arellano, Wendy Stock, Olatoyosi Odenike, Robert L. Redner, Tibor Kovacsovics, Michael W. Deininger, Joshua F. Zeidner, Rebecca L. Olin, Catherine C. Smith, James M. Foran, Gary J. Schiller, Emily K. Curran, Kristin L. Koenig, Nyla A. Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja G. Marcus, Leonard Rosenberg, Brian J. Druker, Ross L. Levine, Amy Burd, Ashley O. Yocum, Uma M. Borate, Alice S. Mims, John C. Byrd, Yazan F. Madanat
Journal: Blood Advances
Blood Adv (2024) 8 (20): 5297–5305.
https://doi.org/10.1182/bloodadvances.2024013685
Published: 2024
Includes: Supplemental data
Journal Articles

Air pollutant impact on disease characteristics and outcomes in patients with acute myeloid leukemia

Andrew Palmer, Garth Rauscher, Ivy Abraham, Madelyn Burkart, Ami Dave, Nepheli Raptis, Ahmed Aleem, Vedavyas Gannamani, Amani Erra, Sarah Monick, Carlos Galvez, Syed Shah, Hamed Rahmani Youshanlouei, Melissa L. Larson, Maryam Zia, Stephanie B. Tsai, Jessica K. Altman, Wendy Stock, Irum Khan, Anand A. Patel
Journal: Blood Advances
Blood Adv (2024) 8 (17): 4647–4650.
https://doi.org/10.1182/bloodadvances.2024013280
Published: 2024
Includes: Supplemental data
Journal Articles

Association of leukemic molecular profile with efficacy of inotuzumab ozogamicin in adults with relapsed/refractory ALL

Yaqi Zhao, A. Douglas Laird, Kathryn G. Roberts, Rolla Yafawi, Hagop Kantarjian, Daniel J. DeAngelo, Matthias Stelljes, Michaela Liedtke, Wendy Stock, Nicola Gökbuget, Susan O’Brien, Elias Jabbour, Ryan D. Cassaday, Melanie R. Loyd, Scott Olsen, Geoffrey Neale, Xueli Liu, Erik Vandendries, Anjali Advani, Charles G. Mullighan
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3226–3236.
https://doi.org/10.1182/bloodadvances.2023012430
Published: 2024
Includes: Supplemental data
Journal Articles

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial

Clinical Trials & Observations
Gail J. Roboz, Guillermo Sanz, Elizabeth A. Griffiths, Karen Yee, Hagop Kantarjian, Christian Récher, Michael T. Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L. O'Connell, Yong Hao, Harold N. Keer, Mohammad Azab, Hartmut Döhner
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2020–2029.
https://doi.org/10.1182/bloodadvances.2023012062
Published: 2024
Includes: Supplemental data
Journal Articles

A study to assess the efficacy of enasidenib and risk-adapted addition of azacitidine in newly diagnosed IDH2 -mutant AML

Clinical Trials & Observations
Sheng F. Cai, Ying Huang, Jennie R. Lance, Hsiaoyin Charlene Mao, Andrew J. Dunbar, Samantha N. McNulty, Todd Druley, Yan Li, Maria R. Baer, Wendy Stock, Tibor Kovacsovics, William G. Blum, Gary J. Schiller, Rebecca L. Olin, James M. Foran, Mark Litzow, Tara Lin, Prapti Patel, Matthew C. Foster, Michael Boyiadzis, Robert H. Collins, Jordan Chervin, Abigail Shoben, Jo-Anne Vergilio, Nyla A. Heerema, Leonard Rosenberg, Timothy L. Chen, Ashley O. Yocum, Franchesca Druggan, Sonja Marcus, Mona Stefanos, Brian J. Druker, Alice S. Mims, Uma Borate, Amy Burd, John C. Byrd, Ross L. Levine, Eytan M. Stein
Journal: Blood Advances
Blood Adv (2024) 8 (2): 429–440.
https://doi.org/10.1182/bloodadvances.2023010563
Published: 2024
Includes: Supplemental data
Journal Articles

Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults

Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Anand A. Patel, Adam DuVall, Peng Wang, Pankhuri Wanjari, Jeremy Segal, Girish Venkataraman, Jason X. Cheng, Sandeep Gurbuxani, Angela Lager, Carrie Fitzpatrick, Michael Thirman, Mariam Nawas, Hongtao Liu, Michael Drazer, Olatoyosi Odenike, Richard Larson, Wendy Stock, Caner Saygin
Journal: Blood Advances
Blood Adv (2023) 8 (1): 164–171.
https://doi.org/10.1182/bloodadvances.2023011862
Published: 2023
Includes: Supplemental data
Journal Articles

Phase 1 study of vibecotamab identifies an optimized dose for treatment of relapsed/refractory acute myeloid leukemia

Clinical Trials & Observations
Farhad Ravandi, Asad Bashey, James Foran, Wendy Stock, Raya Mawad, Nicholas Short, Musa Yilmaz, Hagop Kantarjian, Olatoyosi Odenike, Anand Patel, Raman Garcha, William Barrett Ainsworth, Raphael Clynes, Jitendra Kanodia, Ying Ding, Huajiang Li, Steve Kye, Alice Mims
Journal: Blood Advances
Blood Adv (2023) 7 (21): 6492–6505.
https://doi.org/10.1182/bloodadvances.2023010956
Published: 2023
Includes: Supplemental data
Journal Articles

Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratories

Clinical Trials & Observations
Uma Borate, Fei Yang, Richard Press, Amy S. Ruppert, Dan Jones, Sean Caruthers, Weiqiang Zhao, Jo-Anne Vergilio, Dean C. Pavlick, Luke Juckett, Brianna Norris, Taylor Bucy, Amy Burd, Eytan M. Stein, Prapti Patel, Maria R. Baer, Wendy Stock, Gary Schiller, William Blum, Tibor Kovacsovics, Mark Litzow, James Foran, Nyla A. Heerema, Leonard Rosenberg, Sonja Marcus, Ashley Yocum, Mona Stefanos, Brian Druker, John C. Byrd, Ross L. Levine, Alice Mims
Journal: Blood Advances
Blood Adv (2023) 7 (20): 6048–6054.
https://doi.org/10.1182/bloodadvances.2022009008
Published: 2023
Includes: Supplemental data
Journal Articles

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America

Clinical Trials & Observations
Juan Rangel-Patiño, Yu Ling Lee-Tsai, Victor Itaí Urbalejo-Ceniceros, Maria Elena Monserrat Luna-Perez, Karla Adriana Espinosa-Bautista, Lauro Fabian Amador, Álvaro Cabrera-García, Carolina Balderas-Delgado, Sergio I Inclan-Alarcon, Yvette Neme-Yunes, Jose Manuel Sanchez-Albarrán, Elia Ixel Apodaca, Luis Meillon-García, Wendy Stock, Roberta Demichelis-Gómez
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5202–5209.
https://doi.org/10.1182/bloodadvances.2023009754
Published: 2023
Journal Articles

Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study

Bhavana Bhatnagar, Jessica Kohlschmidt, Shelley J. Orwick, Daelynn R. Buelow, Sydney Fobare, Christopher C. Oakes, Jonathan E. Kolitz, Geoff Uy, Wendy Stock, Bayard L. Powell, Deedra Nicolet, Erin K. Hertlein, Krzysztof Mrózek, James S. Blachly, Ann-Kathrin Eisfeld, Sharyn D. Baker, John C. Byrd
Journal: Blood Advances
Blood Adv (2023) 7 (16): 4671–4675.
https://doi.org/10.1182/bloodadvances.2023010482
Published: 2023
Includes: Supplemental data
Journal Articles

Influence of participant and reviewer characteristics in application scores for a hematology research training program

Sara K. Vesely, Allison King, Emily Vettese, John G. Heller, Adam Cuker, Cecelia Calhoun, Wendy Stock, Morgan Homer, Josel Fritz, Lillian Sung
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4064–4071.
https://doi.org/10.1182/bloodadvances.2023009792
Published: 2023
Includes: Supplemental data
Journal Articles

Pevonedistat with azacitidine in older patients with TP53 -mutated AML: a phase 2 study with laboratory correlates

Clinical Trials & Observations
Antoine N. Saliba, Scott H. Kaufmann, Eytan M. Stein, Prapti A. Patel, Maria R. Baer, Wendy Stock, Michael Deininger, William Blum, Gary J. Schiller, Rebecca L. Olin, Mark R. Litzow, Tara L. Lin, Brian J. Ball, Michael M. Boyiadzis, Elie Traer, Olatoyosi Odenike, Martha L. Arellano, Alison Walker, Vu H. Duong, Tibor Kovacsovics, Robert H. Collins, Abigail B. Shoben, Nyla A. Heerema, Matthew C. Foster, Kevin L. Peterson, Paula A. Schneider, Molly Martycz, Theophilus J. Gana, Leonard Rosenberg, Sonja Marcus, Ashley O. Yocum, Timothy Chen, Mona Stefanos, Alice S. Mims, Uma Borate, Amy Burd, Brian J. Druker, Ross L. Levine, John C. Byrd, James M. Foran
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2360–2363.
https://doi.org/10.1182/bloodadvances.2022008625
Published: 2023
Includes: Supplemental data
Journal Articles

Pembrolizumab for the treatment of disease relapse after allogeneic hematopoietic stem cell transplantation

Clinical Trials & Observations
James Godfrey, Hongtao Liu, Jovian Yu, Michael Tallarico, Emily Curran, Andrew Artz, Peter A. Riedell, Wendy Stock, Theodore Karrison, Carrie Fitzpatrick, Girish Venkataraman, Alan Cooper, Sonali M. Smith, Michael R. Bishop, Justin Kline
Journal: Blood Advances
Blood Adv (2023) 7 (6): 963–970.
https://doi.org/10.1182/bloodadvances.2022008403
Published: 2023
Includes: Supplemental data
Journal Articles

A phase 1 trial utilizing TMI with fludarabine-melphalan in patients with hematologic malignancies undergoing second allo-SCT

Clinical Trials & Observations
Misha C. Tran, Yasmin Hasan, Amy Wang, Kamil Yenice, Julien Partouche, Wendy Stock, Richard A. Larson, Satyajit Kosuri, James L. LaBelle, Justin Kline, Peter A. Riedell, Andrew S. Artz, Ralph Weichselbaum, Michael R. Bishop, Bulent Aydogan, Hongtao Liu
Journal: Blood Advances
Blood Adv (2023) 7 (3): 285–292.
https://doi.org/10.1182/bloodadvances.2022007530
Published: 2023
Includes: Supplemental data
Journal Articles

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study

Clinical Trials & Observations
Ibrahim Aldoss, Jun Yin, Anna Wall, Krzysztof Mrózek, Michaela Liedtke, David F. Claxton, Matthew C. Foster, Frederick R. Appelbaum, Harry P. Erba, Mark R. Litzow, Martin S. Tallman, Richard M. Stone, Richard A. Larson, Anjali S. Advani, Wendy Stock, Selina M. Luger
Journal: Blood Advances
Blood Adv (2023) 7 (2): 196–204.
https://doi.org/10.1182/bloodadvances.2022007791
Published: 2023
Includes: Supplemental data
Journal Articles

D-dimer and risk for thrombosis in adults with newly diagnosed acute lymphoblastic leukemia

Daniela R. Anderson, Wendy Stock, Theodore G. Karrison, Avi Leader
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5146–5151.
https://doi.org/10.1182/bloodadvances.2022007699
Published: 2022
Includes: Supplemental data
Journal Articles

Disparities in trial enrollment and outcomes of Hispanic adolescent and young adult acute lymphoblastic leukemia

Clinical Trials & Observations
Lori Muffly, Jun Yin, Sawyer Jacobson, Anna Wall, Elisa Quiroz, Anjali S. Advani, Selina M. Luger, Martin S. Tallman, Mark R. Litzow, Matthew C. Foster, Harry P. Erba, Frederick R. Appelbaum, Richard A. Larson, Theresa H.M. Keegan, Wendy Stock
Journal: Blood Advances
Blood Adv (2022) 6 (14): 4085–4092.
https://doi.org/10.1182/bloodadvances.2022007197
Published: 2022
Includes: Supplemental data